Regulon

Regulon: R-1271

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
52.579118Pr-0Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
55062 ENSG00000070540 WIPI1 Q5MNZ9
10398 ENSG00000101335 MYL9 P24844
7852 ENSG00000121966 CXCR4 P61073
2995 ENSG00000136732 GYPC P04921
2040 ENSG00000148175 STOM P27105

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
BKT140CXCR4ProteinANTAGONISTC-X-C chemokine receptor type 4 antagonist30
BALIXAFORTIDECXCR4ProteinANTAGONISTC-X-C chemokine receptor type 4 antagonist30
MAVORIXAFORCXCR4Small moleculeANTAGONISTC-X-C chemokine receptor type 4 antagonist30
ULOCUPLUMABCXCR4AntibodyINHIBITORC-X-C chemokine receptor type 4 inhibitor10
BURIXAFORCXCR4Small moleculeANTAGONISTC-X-C chemokine receptor type 4 antagonist20
PLERIXAFORCXCR4Small moleculePARTIAL AGONISTC-X-C chemokine receptor type 4 partial agonist40
MSX-122CXCR4Small moleculeANTAGONISTC-X-C chemokine receptor type 4 antagonist10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1271

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-04183RBPJLdown-regulatesVAX2repressesR-127172Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-04450MYH8down-regulatesVAX2repressesR-127171Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-04729ADAMTS20down-regulatesVAX2repressesR-127172Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-06726ATRXup-regulatesVAX2repressesR-127173Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-15942KCNB2down-regulatesVAX2repressesR-127171Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-19237NF1down-regulatesVAX2repressesR-127175Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-21479POTEFdown-regulatesVAX2repressesR-127171Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122

CMF-22340IDH1up-regulatesVAX2repressesR-127174Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

BKT140, BALIXAFORTIDE, MAVORIXAFOR, ULOCUPLUMAB, BURIXAFOR, PLERIXAFOR, MSX-122